Author

M. R. Farcet

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:proteomics· 3 Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Approach:statistical model· 1

Frequent Co-Authors

T. R. Kreil· 3 shared J. Schwaiger· 2 shared M. Karbiener· 2 shared C. Aberham· 1 shared C. Jungbauer· 1 shared E. Gschaider-Reichhart· 1 shared L. Weidner· 1 shared L. Weseslindtner· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

T. R. Kreil

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivFeb 12, 2021

Rapidly Increasing SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Produced from Plasma Collected During the 2020 Pandemic

M. R. Farcet, M. Karbiener, J. Schwaiger…·T. R. Kreil

The paper analyzes SARS-CoV-2 neutralizing antibody levels in intravenous immunoglobulins (IG) collected during the 2020 pandemic, showing increasing potency over time.

DOI 10.1093/infdis/jiab142

humanproteomics

𝕏 PostBluesky

ImmunologybioRxivJul 30, 2020

No SARS-CoV-2 cross-neutralization by intravenous immunoglobulins produced from plasma collected before the 2020 pandemic

J. Schwaiger, M. Karbiener, C. Aberham…·T. R. Kreil

The paper tests 54 intravenous immunoglobulin preparations from pre-pandemic plasma and finds they neutralize seasonal coronavirus hCoV-229E but not SARS-CoV-2.

DOI 10.1093/infdis/jiaa593

humanproteomics

𝕏 PostBluesky

ImmunologybioRxivJun 21, 2020

Characterization of 100 sequential SARS-CoV-2 convalescent plasma donations

C. Jungbauer, L. Weseslindtner, L. Weidner…·T. R. Kreil

The paper characterizes 100 sequential SARS-CoV-2 convalescent plasma donations to assess neutralizing antibody content and identify donor characteristics for more potent plasma collection.

DOI 10.1111/trf.16119

humanproteomics

𝕏 PostBluesky